Clinical trial
RethinQ Study - Evaluating Pacing in Heart Failure Patients
NCT00132977 · Abbott Medical Devices, Industry · Completed
Key facts
| NCT number | NCT00132977 |
|---|---|
| Title | RethinQ Study - Evaluating Pacing in Heart Failure Patients |
| Official title | Resynchronization Therapy in Normal QRS (RethinQ) Clinical Investigation |
| Acronym | RethinQ |
| Lead sponsor | Abbott Medical Devices, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Failure |
| Intervention type | Device |
| Interventions | Cardiac Resynchronization Therapy |
| Enrollment | 250 |
| Start date | Jul 1, 2005 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Aug 22, 2005 |
| Last update posted | Feb 4, 2019 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: